Inter Parfums (IPAR) Competitors $124.65 -6.07 (-4.64%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends IPAR vs. PBH, EPC, HLF, USNA, NUS, NATR, REV, MED, VERU, and ELShould you be buying Inter Parfums stock or one of its competitors? The main competitors of Inter Parfums include Prestige Consumer Healthcare (PBH), Edgewell Personal Care (EPC), Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Revlon (REV), Medifast (MED), Veru (VERU), and Estée Lauder Companies (EL). Inter Parfums vs. Prestige Consumer Healthcare Edgewell Personal Care Herbalife USANA Health Sciences Nu Skin Enterprises Nature's Sunshine Products Revlon Medifast Veru Estée Lauder Companies Inter Parfums (NASDAQ:IPAR) and Prestige Consumer Healthcare (NYSE:PBH) are both mid-cap consumer discretionary companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, community ranking, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk. Does the MarketBeat Community believe in IPAR or PBH? Prestige Consumer Healthcare received 30 more outperform votes than Inter Parfums when rated by MarketBeat users. Likewise, 70.77% of users gave Prestige Consumer Healthcare an outperform vote while only 64.65% of users gave Inter Parfums an outperform vote. CompanyUnderperformOutperformInter ParfumsOutperform Votes45964.65% Underperform Votes25135.35% Prestige Consumer HealthcareOutperform Votes48970.77% Underperform Votes20229.23% Does the media prefer IPAR or PBH? In the previous week, Inter Parfums had 16 more articles in the media than Prestige Consumer Healthcare. MarketBeat recorded 35 mentions for Inter Parfums and 19 mentions for Prestige Consumer Healthcare. Prestige Consumer Healthcare's average media sentiment score of 0.51 beat Inter Parfums' score of 0.33 indicating that Prestige Consumer Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inter Parfums 9 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Prestige Consumer Healthcare 6 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is IPAR or PBH more profitable? Prestige Consumer Healthcare has a net margin of 18.54% compared to Inter Parfums' net margin of 10.60%. Inter Parfums' return on equity of 16.34% beat Prestige Consumer Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Inter Parfums10.60% 16.34% 10.82% Prestige Consumer Healthcare 18.54%12.23%6.14% Do institutionals and insiders have more ownership in IPAR or PBH? 55.6% of Inter Parfums shares are owned by institutional investors. Comparatively, 99.9% of Prestige Consumer Healthcare shares are owned by institutional investors. 43.9% of Inter Parfums shares are owned by company insiders. Comparatively, 1.6% of Prestige Consumer Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has preferable valuation & earnings, IPAR or PBH? Prestige Consumer Healthcare has lower revenue, but higher earnings than Inter Parfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Inter Parfums, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInter Parfums$1.42B2.81$152.65M$4.6626.75Prestige Consumer Healthcare$1.11B3.66$209.34M$4.1120.04 Which has more volatility & risk, IPAR or PBH? Inter Parfums has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500. Comparatively, Prestige Consumer Healthcare has a beta of 0.47, meaning that its share price is 53% less volatile than the S&P 500. Is IPAR or PBH a better dividend stock? Inter Parfums pays an annual dividend of $3.00 per share and has a dividend yield of 2.4%. Prestige Consumer Healthcare pays an annual dividend of $1.90 per share and has a dividend yield of 2.3%. Inter Parfums pays out 64.4% of its earnings in the form of a dividend. Prestige Consumer Healthcare pays out 46.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Do analysts rate IPAR or PBH? Inter Parfums currently has a consensus price target of $157.50, indicating a potential upside of 26.35%. Prestige Consumer Healthcare has a consensus price target of $83.67, indicating a potential upside of 1.59%. Given Inter Parfums' stronger consensus rating and higher possible upside, equities analysts plainly believe Inter Parfums is more favorable than Prestige Consumer Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inter Parfums 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Prestige Consumer Healthcare 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 SummaryInter Parfums beats Prestige Consumer Healthcare on 12 of the 20 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get Inter Parfums News Delivered to You Automatically Sign up to receive the latest news and ratings for IPAR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IPAR vs. The Competition Export to ExcelMetricInter ParfumsToilet preparations IndustryDiscretionary SectorNASDAQ ExchangeMarket Cap$3.99B$11.71B$8.14B$8.66BDividend Yield2.30%3.16%2.73%4.06%P/E Ratio26.7530.5518.7317.46Price / Sales2.8120.257.4069.04Price / Cash24.1219.4633.9536.36Price / Book4.058.523.625.87Net Income$152.65M$353.66M$261.75M$225.66M7 Day Performance-2.79%-1.15%-3.30%-1.34%1 Month Performance3.53%-2.44%-2.65%1.15%1 Year Performance-1.72%6.09%14.88%24.02% Inter Parfums Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IPARInter Parfums4.4285 of 5 stars$124.65-4.6%$157.50+26.4%-1.8%$3.99B$1.32B26.75530Analyst ForecastShort Interest ↑Analyst RevisionNews CoveragePBHPrestige Consumer Healthcare3.7771 of 5 stars$81.76+0.0%N/A+39.6%$4.05B$1.13B19.89540Insider SellingAnalyst RevisionEPCEdgewell Personal Care3.7011 of 5 stars$36.18+0.1%N/A-1.8%$1.78B$2.25B18.466,800Short Interest ↓Positive NewsHLFHerbalife4.0771 of 5 stars$8.59-0.9%N/A-37.6%$865.80M$5.00B10.119,200USNAUSANA Health Sciences2.8527 of 5 stars$40.79-1.2%N/A-11.8%$777.46M$861.97M14.411,800NUSNu Skin Enterprises4.0068 of 5 stars$7.25+0.4%N/A-57.3%$360.34M$1.78B-3.503,700NATRNature's Sunshine Products2.9504 of 5 stars$17.43+17.0%N/A-7.1%$322.63M$445.32M19.81814Positive NewsREVRevlonN/AN/AN/AN/A$211.59M$2.08B-0.555,800Analyst ForecastMEDMedifast2.59 of 5 stars$19.22-1.1%N/A-72.7%$210.23M$674.48M29.12870Positive NewsVERUVeru2.6645 of 5 stars$0.71-1.6%N/A-41.6%$104.00M$16.30M-1.48189Positive NewsELEstée Lauder Companies4.8029 of 5 stars$63.18-2.2%N/A-48.0%$22.68B$15.61B112.8262,000Short Interest ↑ Related Companies and Tools Related Companies PBH Competitors EPC Competitors HLF Competitors USNA Competitors NUS Competitors NATR Competitors REV Competitors MED Competitors VERU Competitors EL Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IPAR) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inter Parfums, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inter Parfums With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
